Aankondiging • Jun 01
Facephi Biometria, S.A., Annual General Meeting, Jun 29, 2026 Facephi Biometria, S.A., Annual General Meeting, Jun 29, 2026. Location: avenida perfecto palacio de la fuente 6, alicante., Spain Aankondiging • May 05
Facephi Biometria, S.A. Provides Earnings Guidance for 2026 Facephi Biometria, S.A. provided earnings guidance for 2026. The company reiterated revenue EUR 46.2 million (+28.4%). Aankondiging • Apr 14
Facephi Biometria, S.A. to Report Fiscal Year 2025 Results on Apr 29, 2026 Facephi Biometria, S.A. announced that they will report fiscal year 2025 results at 5:30 PM, Romance Standard Time on Apr 29, 2026 New Risk • Nov 05
New minor risk - Profitability The company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €7.9m Forecast net loss in 2 years: €1.6m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€1.6m net loss in 2 years). Share price has been volatile over the past 3 months (8.5% average weekly change). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€73.2m market cap, or US$84.1m). Aankondiging • Nov 01
Facephi Biometria, S.A. Provides Earnings Guidance for the Fiscal Years 2025 and 2026 Facephi Biometria, S.A. provided earnings guidance for the fiscal years 2025 and 2026. For the year 2025, the company expects net revenue of €36.4 million.
For the year 2026, the company expects net revenue of €46.2 million. Aankondiging • Oct 07
Facephi Biometria, S.A. to Report First Half, 2025 Results on Oct 30, 2025 Facephi Biometria, S.A. announced that they will report first half, 2025 results on Oct 30, 2025 New Risk • Sep 10
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 18% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€68.7m market cap, or US$80.4m). Aankondiging • Aug 07
Facephi Launches Advanced Injection Defense Against Deepfakes and AI-Powered Injection Attacks Facephi Biometria, SA has launched Advanced Injection Defense -- a powerful new add-on to its Behavioral Biometrics Solution that brings enhanced protection against deepfakes, spoofing, and manipulated digital content. As the threat landscape evolves, tools capable of creating high-precision fake images and videos are being increasingly used to compromise digital identity systems. Advanced Injection Defense directly addresses this challenge by combining artificial intelligence, forensic image analysis, and real-time capture validation to detect and block even the most convincing injection attacks. This new feature protects against: Injection of pre-recorded or manipulated media; Device emulation and screen replay attacks; Tampering of capture channels and data flows. By analyzing both the image content and the context of capture, Advanced Injection Defense flags anomalies such as simulation, substitution, or manipulation attempts. It enables organizations to verify digital identities with greater certainty and precision. Now available as an add-on to Facephi's Behavioral Biometrics suite, Advanced Injection Defense can be integrated into both new customer onboarding and ongoing authentication processes. It meets rigorous global compliance requirements and is suited for high-risk sectors including: Banking and Financial Services; Healthcare and Insurance; Telecommunications; Government and Public Administration. New Risk • Jul 01
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risk Market cap is less than US$100m (€66.2m market cap, or US$78.0m). New Risk • Jun 17
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -€4.5m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-€4.5m free cash flow). Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€63.4m market cap, or US$73.1m). Aankondiging • May 19
Facephi Biometria, S.A., Annual General Meeting, Jun 16, 2025 Facephi Biometria, S.A., Annual General Meeting, Jun 16, 2025. Location: avenida perfecto palacio de la fuente 6, edificio panoramis, alicante., Spain Reported Earnings • May 01
Full year 2024 earnings released Full year 2024 results: Revenue: €33.5m (up 14% from FY 2023). Net loss: €8.88m (loss widened 106% from FY 2023). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Software industry in Germany. New Risk • Apr 15
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 18% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€60.9m market cap, or US$68.8m). Aankondiging • Mar 13
Facephi Accelerates the Digitalization of the Air Travel with Verified Identity and its KYP (Know Your Passenger) Solution at the IATA World Data Symposium Facephi has reinforced its commitment to transforming the aviation sector at the IATA World Data Symposium. At this key industry event, the company showcased several solutions aimed at enabling a fully digital air travel experience, aligning with IATA's One ID initiative, which seeks to eliminate airport frictionless through verifiable credentials and facial biometrics. Currently, passengers must verify their identity at multiple checkpoints throughout a single journey, leading to delays and increased congestion at airports. To address this challenge, Facephi has developed technology that enables identity validation before arriving at the airport, reducing wait times and ensuring a seamless and secure travel experience. This innovation has already been successfully tested in collaboration with IATA through a proof of concept conducted last November. Complementing other solutions that have proven to reduce processing times by 40%, Facephi advocates for a decentralized model that enhances security and privacy. By leveraging verifiable credentials (VCs) and secure digital wallets, passengers have full control over when and how they share their personal information, ensuring compliance with global data protection regulations. Facephi's approach integrates advanced biometric verification with strong customer authentication (SCA) technologies, enabling fast, contactless identification at every checkpoint. From passport scanning to generating a Type 1 Digital Travel Credential (DTC) and creating verifiable credentials, travelers can securely store and manage their digital identity, streamlining check-in, security checks, and boarding processes. Setting new standards for interoperability: By aligning with IATA's core principles, Facephi ensures interoperability standards between airlines, airports, and government authorities. With the creation of VCs at a Level of Assurance High (Immigration Level) that can be used by government entities, Facephi reaffirms its leadership in aviation digitalization. The company's strong commitment to this industry translates into innovative solutions that not only optimize operational efficiency at airports but also empower passengers by giving them greater control over their digital identity. Aankondiging • Mar 02
Facephi Biometria, SA Unveils Know Your Passenger at IATA’s World Data Symposium Facephi Biometria, SA is showcasing its Know Your Passenger (KYP) solution to revolutionize air travel at IATA's World Data Symposium (WDS) in Dublin on February 26th and 27th, 2025. It follows the success of Facephi's digital travel test, conducted last November, in collaboration with the International Air Transport Association (IATA) and other companies, that enabled travelers to complete a round trip between Hong Kong and Narita (Tokyo) without the need for physical credentials, marking a pivotal step toward the future of 100% digital air travel. At IATA's World Data Sym Symposium, Facephi will showcase how KYP is setting new standards in seamless passenger experiences. This solution enhances security, while streamlining travel, eliminating the need for physical documents, and offering a faster, contactless, and highly efficient journey. Key Features of KYP: Seamless digital onboarding: Verified identity before arriving at the airport. Experience adapted to each passenger. The passenger controls how and when to share their data. Phishing-resistant authentication: A secure, passwordless, and friction-free experience with Strong Customer Authentication (SCA). Compliance with global standards: Meeting eIDAS, ICAO, and other regulatory requirements. New Risk • Jan 31
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risk Market cap is less than US$100m (€48.2m market cap, or US$50.2m). New Risk • Dec 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Shareholders have been diluted in the past year (7.6% increase in shares outstanding). Market cap is less than US$100m (€36.9m market cap, or US$38.2m). Reported Earnings • Oct 23
First half 2024 earnings released First half 2024 results: Revenue: €14.1m (up 19% from 1H 2023). Net loss: €6.29m (loss widened 34% from 1H 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Software industry in Germany. Aankondiging • May 31
Facephi Biometria, S.A., Annual General Meeting, Jun 28, 2024 Facephi Biometria, S.A., Annual General Meeting, Jun 28, 2024. Location: avenida perfecto palacio de la fuente 6, edificiopanoramis, alicante., Spain New Risk • May 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 39% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (7.4% average weekly change). Shareholders have been diluted in the past year (22% increase in shares outstanding). Market cap is less than US$100m (€44.1m market cap, or US$48.0m). Aankondiging • Mar 25
Facephi Biometria, S.A. announced that it expects to receive funding from Hancom Inc. Facephi Biometria, S.A. announced that it has entered into an investment agreement with returning investor Hancom Inc. to issue common shares on March 25, 2024. New Risk • Nov 22
New major risk - Revenue and earnings growth Earnings have declined by 39% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 39% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (14% increase in shares outstanding). Market cap is less than US$100m (€47.9m market cap, or US$52.3m). New Risk • Nov 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Large one-off items impacting financial results. Shareholders have been diluted in the past year (14% increase in shares outstanding). Market cap is less than US$100m (€47.5m market cap, or US$51.6m). Valuation Update With 7 Day Price Move • Nov 09
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to €2.46, the stock trades at a trailing P/E ratio of 41.4x. Average forward P/E is 28x in the Software industry in Germany. Total loss to shareholders of 57% over the past three years. New Risk • Oct 05
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10% average weekly change). Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (14% increase in shares outstanding). Market cap is less than US$100m (€46.0m market cap, or US$48.4m). Valuation Update With 7 Day Price Move • Jul 28
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to €2.79, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 24x in the Software industry in Germany. Total loss to shareholders of 47% over the past three years. Valuation Update With 7 Day Price Move • May 14
Investor sentiment deteriorates as stock falls 21% After last week's 21% share price decline to €2.44, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 26x in the Software industry in Germany. Total loss to shareholders of 56% over the past three years. Board Change • Nov 16
Less than half of directors are independent There are 6 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 6 new directors. 3 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Vice President of the Board Fernando Orteso De Travesedo is the most experienced director on the board, commencing their role in 2015. Independent Director Pablo Boranat was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Nov 10
First half 2022 earnings released First half 2022 results: Revenue: €9.72m (up 98% from 1H 2021). Net loss: €1.07m (loss narrowed 37% from 1H 2021). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Software industry in Germany. Reported Earnings • May 01
Full year 2021 earnings released Full year 2021 results: Revenue: €15.3m (up 89% from FY 2020). Net loss: €553.9k (loss narrowed 67% from FY 2020). Board Change • Apr 27
Less than half of directors are independent There are 7 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 7 new directors. 2 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Fernando Orteso De Travesedo is the most experienced director on the board, commencing their role in 2015. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • May 25
Full year 2020 earnings released The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: €8.13m (down 7.5% from FY 2019). Net loss: €1.68m (down 231% from profit in FY 2019). Valuation Update With 7 Day Price Move • Feb 03
Investor sentiment deteriorated over the past week After last week's 15% share price decline to €3.79, the stock is trading at a trailing P/E ratio of 53.4x, down from the previous P/E ratio of 62.9x. This compares to an average P/E of 29x in the Software industry in Germany. Is New 90 Day High Low • Feb 03
New 90-day low: €3.79 The company is down 31% from its price of €5.46 on 04 November 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 14% over the same period. Is New 90 Day High Low • Jan 19
New 90-day low: €4.79 The company is down 16% from its price of €5.70 on 20 October 2020. The German market is up 9.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Software industry, which is down 18% over the same period. Is New 90 Day High Low • Dec 30
New 90-day low: €4.98 The company is down 14% from its price of €5.76 on 01 October 2020. The German market is up 9.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Software industry, which is down 16% over the same period. Is New 90 Day High Low • Dec 08
New 90-day low: €5.30 The company is down 4.0% from its price of €5.52 on 09 September 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Software industry, which is down 21% over the same period. Aankondiging • Sep 24
Facephi Biometria, S.A. has completed a Follow-on Equity Offering in the amount of €0.699995 million. Facephi Biometria, S.A. has completed a Follow-on Equity Offering in the amount of €0.699995 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 152,744
Price\Range: €4.5828 
